Delhi AIIMS to get new Jan Aushadhi Kendra on October 29
New Delhi: In an effort to ensure access to affordable and quality medicines, Prime Minister Narendra Modi is set to inaugurate a new Jan Aushadhi Kendra at the All India Institute of Medical Sciences (AIIMS), New Delhi, on October 29.
The event will also be attended by Jagat Prakash Nadda, the Union Minister of Chemicals and Fertilizers and Health and Family Welfare.
The main objective of this Kendra will be to provide affordable and quality medicines to the patients visiting AIIMS for the treatment of various ailments.
According to an ANI report, the press release stated that the new Kendra, spanning an area of 1,724 square feet, aims to provide over 2,047 quality generic medicines and 300 surgical devices at prices significantly lower than their branded counterparts.
Also Read:Dr Mansukh Mandaviya inaugurates Credit Assistance Program for Jan Aushadhi Kendras
The available medicines will cover a wide array of therapeutic groups, including cardiovascular health, anti-cancer treatments, anti-diabetics, anti-infectives, anti-allergic medications, gastrointestinal solutions, and nutraceuticals.
This initiative will revolutionize healthcare access for thousands of patients each day who flock to AIIMS, New Delhi each day in search of affordable, high-quality medical solutions.
The establishment of this Jan Aushadhi Kendra represents a monumental leap forward in the government's commitment to ensuring that essential medicines are not just a privilege for the few, but a right for all.
In a bustling medical hub like AIIMS, renowned for its cutting-edge treatments and expert care, this Kendra will serve as a beacon of hope and illuminate the path toward equitable healthcare for all citizens, regardless of their economic background.
Presently, more than 14,000 Jan Aushadhi Kendras are operating across India, delivering health benefits to approximately one million people every single day.
These Kendras extend their life-saving services into the farthest corners of the nation, reaching the most remote and underserved areas, across 780 districts.
The Government of India is not resting on its laurels; ambitious plans are underway to expand this formidable network to 25,000 Kendras over the next two years.
This visionary expansion will not only enhance the availability of affordable healthcare but will also empower millions of citizens to access the medicines they need, fostering a healthier, more resilient India for generations to come.
The inauguration of Jan Aushadhi Kendra at AIIMS marks a historic milestone in the relentless efforts of the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) to reshape the healthcare landscape of India, news agency ANI reported.
This Kendra is not merely an addition to the existing facilities; it stands as a beacon of hope for countless patients seeking affordable treatment options in New Delhi.
By providing a vast array of high-quality generic medicines at prices that are a fraction of branded counterparts, this initiative will serve as an indispensable lifeline for those who have long struggled with the prohibitive costs of healthcare.
It symbolizes a transformative shift towards a more inclusive healthcare system, where quality treatment is accessible to all, regardless of socioeconomic status.
This initiative also reaffirms the government's steadfast dedication to promoting health equity, ensuring that no citizen is left behind in the pursuit of quality healthcare.
It embodies the vision of a fairer society where every individual, from urban centres to remote villages, can access essential medicines without financial strain.
The Jan Aushadhi Kendra at AIIMS is a powerful testament to the government's commitment to fostering a healthier nation, empowering individuals with the right to affordable healthcare, and fundamentally transforming the way healthcare is perceived and delivered across India. With this Kendra, we are not just improving health outcomes; we are igniting hope and restoring dignity to countless lives.
Also Read:Pradhan Mantri Bhartiya Janaushadhi Pariyojana achieves target of Rs 1000 crore in sales in FY 2023-24
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.